CANDEL THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
CANDEL THERAPEUTICS, INC. (CADL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 8.79 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.79M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.44M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 6.25M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 6.21M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2026-06-30 | 8.79M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 8.44M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 6.25M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 6.21M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 6.14M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 5.92M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 4.49M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 4.60M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 4.68M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 5.11M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 5.67M shares 10-K · filed 2025-03-13 |
| 2023-09-30 | 6.06M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 6.42M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 5.48M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 5.65M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 6.19M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 5.65M shares 10-Q · filed 2022-08-05 |
| 2022-03-31 | 5.82M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 4.78M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 4.69M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 4.61M shares 10-Q · filed 2021-09-08 |
| 2020-12-31 | 4.01M shares 10-K · filed 2022-03-29 |
| 2019-12-31 | 928.29K shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |